McKesson Corporation (MCK): financials, SEC filings and peers

McKesson Corporation (MCK) is a health care distributors company in the Health Care sector of the S&P 500, headquartered in Irving, Texas.

It was founded in 1833 and joined the S&P 500 on January 13, 1999.

Its fiscal year ends in March, and its shares trade on the NYSE.

In its SEC filings it is classified as “Wholesale-Drugs, Proprietaries & Druggists' Sundries”.

McKesson Corporation at a glance

Revenue (12 months): $411.0B
Revenue growth: +8.8%
Operating margin: 1.6%
Net income (12 months): $4.6B
Free cash flow (12 months): $6.4B
Cash: $5.2B
Debt: $9.7B
Diluted EPS (12 months): $37.31

Twelve months to June 30, 2026, from the 10-Q filed August 5, 2026.

Latest twelve months

Over the twelve months to June 30, 2026, McKesson Corporation reported revenue of $411.0 billion, up 8.8% from a year earlier.

Its operating margin was 1.6%: for every $100 of sales, about $2 was left as operating profit.

Net income was $4.6 billion (1.1% of revenue), 45.1% higher than a year earlier.

Operating cash flow was $6.9 billion and capital spending $437 million, leaving free cash flow of $6.4 billion (1.6% of revenue).

At the end of the period it held $5.2 billion in cash and $9.7 billion in debt, a net debt position of $4.6 billion.

The diluted share count fell 5.0% in a year, typically the result of buybacks.

Five-year trend

Revenue went from $238.2 billion in fiscal 2021 to $403.4 billion in fiscal 2026, about 11.1% a year.
Revenue has grown for 5 fiscal years in a row.
Operating margin widened from -2.1% to 1.5% over the same years.
Free cash flow was positive in each of the last 6 fiscal years.
McKesson Corporation reported a net loss in 1 of the last 6 fiscal years.

Fiscal year	2022	2023	2024	2025	2026
Revenue	$264.0B	$276.7B	$309.0B	$359.1B	$403.4B
Revenue growth	10.8%	4.8%	11.7%	16.2%	12.4%
Operating margin	0.8%	1.6%	1.3%	1.2%	1.5%
Net income	$1.1B	$3.6B	$3.0B	$3.3B	$4.8B
Free cash flow	$4.0B	$4.8B	$3.9B	$5.5B	$5.7B
Diluted EPS	$7.23	$25.03	$22.39	$25.72	$38.38

Fiscal years as reported in McKesson Corporation’s 10-K filings. Free cash flow is operating cash flow minus capital spending.

Recent SEC filings

8-K filed August 28, 2026 — Regulation FD disclosure
10-Q filed August 5, 2026 — quarterly report
8-K filed August 5, 2026 — Earnings results
8-K filed July 24, 2026 — Shareholder vote results
8-K filed July 1, 2026 — Executive or director change; Regulation FD disclosure
8-K filed June 12, 2026 — Material agreement; New debt obligation
10-K filed May 8, 2026 — annual report
8-K filed May 7, 2026 — Earnings results

All McKesson Corporation filings on SEC EDGAR

Companies like McKesson Corporation

Other S&P 500 companies in Health Care Distributors:

More from Health Care

All 60 Health Care companies →

Questions about McKesson Corporation

Is McKesson Corporation's revenue growing?

Yes. Revenue for the twelve months to June 30, 2026 was $411.0 billion, up 8.8% from a year earlier, according to its SEC filings.

Is McKesson Corporation profitable?

Yes. It earned $4.6 billion in net income over the twelve months to June 30, 2026, a net margin of 1.1%.

Does McKesson Corporation have more cash or more debt?

At June 30, 2026 it had $5.2 billion in cash and $9.7 billion in debt, so more debt than cash.

When did McKesson Corporation last file financial results?

Its latest quarterly report (10-Q) was filed with the SEC on August 5, 2026.

Which companies are similar to McKesson Corporation?

In the S&P 500, McKesson Corporation is grouped in Health Care Distributors within the Health Care sector. Cardinal Health (CAH), Cencora (COR), Henry Schein (HSIC) are in the same group.

Understand the numbers

Source: McKesson Corporation’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved September 27, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.